OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, et al.
The European Journal of Health Economics (2017) Vol. 19, Iss. 3, pp. 435-446
Open Access | Times Cited: 31
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, et al.
The European Journal of Health Economics (2017) Vol. 19, Iss. 3, pp. 435-446
Open Access | Times Cited: 31
Showing 26-50 of 31 citing articles:
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab
Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e067516-e067516
Open Access | Times Cited: 1
Korinna Karampampa, Hanna Gyllensten, Emilie Friberg, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e067516-e067516
Open Access | Times Cited: 1
Cognitive function predicts work disability among multiple sclerosis patients
Andrius Kavaliūnas
(2017)
Open Access | Times Cited: 2
Andrius Kavaliūnas
(2017)
Open Access | Times Cited: 2
Alemtuzumab and prescription medication use in the MS population
Aníbal Chertcoff, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 42, pp. 102086-102086
Closed Access | Times Cited: 1
Aníbal Chertcoff, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 42, pp. 102086-102086
Closed Access | Times Cited: 1
Most costs of illness in MS patients are indirect costs
PharmacoEconomics & Outcomes News (2017) Vol. 778, Iss. 1, pp. 25-25
Closed Access
PharmacoEconomics & Outcomes News (2017) Vol. 778, Iss. 1, pp. 25-25
Closed Access
How Cost-of-Illness (COI) Study Provides Direct and Indirect Costs of Multiple Sclerosis (MS) in Bosnia and Herzegovina ?
Tarik Čatić, Enra Suljić, Refet Gojak, et al.
Materia Socio Medica (2018) Vol. 30, Iss. 4, pp. 270-270
Open Access
Tarik Čatić, Enra Suljić, Refet Gojak, et al.
Materia Socio Medica (2018) Vol. 30, Iss. 4, pp. 270-270
Open Access
Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator
Lucía Romero, Laura Bau, Elisabet Matas, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267504-e0267504
Open Access
Lucía Romero, Laura Bau, Elisabet Matas, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267504-e0267504
Open Access
